Astrocyte-conditional knockout of MOB2 inhibits the phenotypic conversion of reactive astrocytes from A1 to A2 following spinal cord injury in mice
- PMID: 39863205
- DOI: 10.1016/j.ijbiomac.2025.140289
Astrocyte-conditional knockout of MOB2 inhibits the phenotypic conversion of reactive astrocytes from A1 to A2 following spinal cord injury in mice
Abstract
After spinal cord injury (SCI), reactive astrocytes in the injured area are triggered after spinal cord injury (SCI) and to polarize into A1 astrocytes with a proinflammatory phenotype or A2 astrocytes with an anti-inflammatory phenotype. Monopolar spindle binder 2 (MOB2) induces astrocyte stellation, maintains cell homeostasis, and promotes neurite outgrowth; however, its role in the phenotypic transformation of reactive astrocytes remains unclear. Here, we confirmed for the first time that MOB2 is associated with A1/A2 phenotypic switching in reactive astrocytes following SCI in mice. MOB2 modulated A1/A2 transformation in a primary astrocyte reactive cell model. Therefore, we constructed MOB2 conditional knockout mice (MOB2GFAP-CKO) and discovered that conditional knockout of MOB2 inhibited the conversion of reactive astrocytes from A1 to A2 and hindered spinal cord function recovery. Mechanistically, MOB2 increased the activation of PI3K-AKT signaling to promote A1/A2 transformation in vitro, whereas sc79 (an AKT activator) reversed the subtype transformation of reactive astrocytes and improved functional recovery in MOB2GFAP-CKO mice after SCI. Taken together, study provides the first insights into how MOB2 acts as a novel regulator to promote the conversion this of the reactive astrocyte phenotype from A1 to A2, showing great potential for the treatment of SCI.
Keywords: MOB2; PI3K-AKT signaling; Spinal cord injury.
Copyright © 2025 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
HSF1 is involved in suppressing A1 phenotype conversion of astrocytes following spinal cord injury in rats.J Neuroinflammation. 2021 Sep 16;18(1):205. doi: 10.1186/s12974-021-02271-3. J Neuroinflammation. 2021. PMID: 34530848 Free PMC article.
-
Hypoxic-preconditioned mesenchymal stem cell-derived small extracellular vesicles promote the recovery of spinal cord injury by affecting the phenotype of astrocytes through the miR-21/JAK2/STAT3 pathway.CNS Neurosci Ther. 2024 Mar;30(3):e14428. doi: 10.1111/cns.14428. Epub 2023 Aug 29. CNS Neurosci Ther. 2024. PMID: 37641874 Free PMC article.
-
Knockout of microglial Hv1 proton channel reduces neurotoxic A1 astrocytes and neuronal damage via the ROS/STAT3 pathway after spinal cord injury.Glia. 2023 Oct;71(10):2418-2436. doi: 10.1002/glia.24433. Epub 2023 Jul 3. Glia. 2023. PMID: 37395288
-
Inhibition of A1 Astrocytes and Activation of A2 Astrocytes for the Treatment of Spinal Cord Injury.Neurochem Res. 2023 Mar;48(3):767-780. doi: 10.1007/s11064-022-03820-9. Epub 2022 Nov 23. Neurochem Res. 2023. PMID: 36418652 Review.
-
Reactive Astrogliosis: Implications in Spinal Cord Injury Progression and Therapy.Oxid Med Cell Longev. 2020 Aug 19;2020:9494352. doi: 10.1155/2020/9494352. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32884625 Free PMC article. Review.
Cited by
-
Astrocyte in Neurological Disease: Pathogenesis and Therapy.MedComm (2020). 2025 Jul 17;6(8):e70299. doi: 10.1002/mco2.70299. eCollection 2025 Aug. MedComm (2020). 2025. PMID: 40686921 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous